33 Results for "

glycogen synthase kinase-3β

" in MedChemExpress (MCE) Product Catalog:
Products (33)

33 Results for "glycogen synthase kinase-3β" in MCE Product Catalog:

6
6 Publications Verification
Cat. No.: HY-113914
CAS No.: 1034895-42-5
Purity:  99.13%
Synonyms: Elraglusib
Target:  

GSK-3 Apoptosis Autophagy

Research Areas:  

Cancer

9-ING-41 (Elraglusib) is a maleimide-based ATP-competitive and selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 0.71 μM. 9-ING-41 significantly leads to cell cycle arrest, autophagy and apoptosis in cancer cells. 9-ING-41 has anticancer activity and has the potential for enhancing the antitumor effects of chemotherapeutic agents .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-59090
CAS No.: 676596-65-9
Synonyms: 1-Akp
Target:  

GSK-3

1-Azakenpaullone (1-Akp) is a highly selective and ATP-competitive inhibitor of glycogen synthase kinase-3 β (GSK-3β), with an IC50 value of 18 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-P80820
Synonyms: GSK3B; glycogen synthase kinase-3 beta; GSK-3 beta; Serine/threonine-protein kinase GSK3B

Host:  

Rabbit

Application:  

WB, IHC-F, IHC-P, ICC/IF

Reactivity:  

Human, Mouse, Rat

loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-121035
CAS No.: 916440-85-2
Purity:  99.20%
Synonyms: 7-Bromoindirubin-3-Oxime
Target:  

CDK GSK-3

Research Areas:  

Neurological Disease

7BIO (7-Bromoindirubin-3-Oxime) is the derivate of indirubin. 7BIO (7-Bromoindirubin-3-Oxime) has inhibitory effects against cyclin-dependent kinase-5 (CDK5) and glycogen synthase kinase-3β (GSK3β). 7BIO (7-Bromoindirubin-3-Oxime) inhibits Aβ oligomer-induced neuroinflammation, synaptic impairments, tau hyper-phosphorylation, activation of astrocytes and microglia, and attenuates Aβ oligomer-induced cognitive impairments in mice [1].
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-141480
CAS No.: 1448990-73-5
Purity:  99.22%
Target:  

GSK-3 Apoptosis

Research Areas:  

Cancer

GSK-3β inhibitor 3 is a potent, selective, irreversible and covalent inhibitor of Glycogen Synthase Kinase 3β (GSK-3β), with an IC50 of 6.6 μM. GSK-3β inhibitor 3 can be used for the research of acute promyelocytic leukemia .
loading...
    loading...
Cat. No.: HY-139254
CAS No.: 667463-82-3
Purity:  99.10%
Synonyms: IDR3O; I3O
Target:  

CDK GSK-3 JNK Wnt

Research Areas:  

Neurological Disease

Indirubin-3′-oxime (IDR3O), a synthetic derivative of indirubin, is a potent inhibitor of cyclin-dependent kinases (CDKs) and glycogen synthase kinase 3β (GSK3β). Indirubin-3′-oxime directly inhibits the activity of all three isoforms of JNK (JNK1, JNK2, and JNK3), with IC50s of 0.8 μM, 1.4 μM, and 1.0 μM, respectively. Indirubin-3′-oxime can enhance height growth via activation of Wnt/β-catenin signaling in chondrocytes .
loading...
    loading...
Cat. No.: HY-P10605
CAS No.: 496856-73-6
Target:  

Akt GSK-3

Research Areas:  

Cancer

GSK3β-peptide is a substrate mimetic peptide of glycogen synthase kinase 3-β (GSK3-β) that can bind to the active site of GSK3-β and mimic the behavior of a real substrate. GSK3β-peptide can be used to develop substrate mimetic inhibitors of Akt as potential anticancer drugs .
loading...
    loading...
Cat. No.: HY-126144A
CAS No.: 3367-88-2
Purity:  99.03%
Target:  

GSK-3

Research Areas:  

Metabolic Disease

(E/Z)-GSK-3β inhibitor 1 is a racemic compound of (E)-GSK-3β inhibitor 1 and (Z)-GSK-3β inhibitor 1 isomers. GSK-3β inhibitor 1 (compound 3a) is a glycogen synthase kinase 3β (GSK-3β) inhibitor and demonstrates high antidiabetic efficacy, with an IC50 of 4.9 nM .
loading...
    loading...
Cat. No.: HY-169632
CAS No.: 757198-76-8
Target:  

GSK-3

Research Areas:  

Neurological Disease

GSK3β-IN-1 (compound 1) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=65 nM), which can be used in the study of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-148132
CAS No.: 536731-65-4
Purity:  98.02%
Target:  

GSK-3

Research Areas:  

Neurological Disease

GSK-3β inhibitor 11 (compound 21) is a glycogen synthase kinase-3β (GSK-3β) inhibitor (IC50=10.02 μM). GSK-3β inhibitor 11 can be used in neurodegenerative disease research .
loading...
    loading...
Cat. No.: HY-175850
Target:  

GSK-3 Apoptosis NF-κB c-Myc

Research Areas:  

Cancer

GSK-3β inhibitor 28 is selective and non-competitivea glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 14.82 nM. GSK-3β inhibitor 28 can upregulate the expression level of phosphorylated GSK-3β and downregulate the expression of p-NF-κB, P65, C-myc and Cyclin D1. GSK-3β inhibitor 28 can induce cells apoptosis, G1 phase arrest and inhibit migration. GSK-3β inhibitor 28 can be used for the research of cancer, such as colorectal cancer .
loading...
    loading...
Cat. No.: HY-W780130
CAS No.: 1333381-77-3
Research Areas:  

Inflammation/Immunology

SkQR1 hydroxide is a mitochondrial targeted antioxidant. SkQR1 hydroxide can inhibit glycogen synthase kinase 3β (GSK3β) in the brain. SkQR1 hydroxide has a significant memory promoting effect. SkQR1 hydroxide can be used for research related to brain memory .
loading...
    loading...
Cat. No.: HY-133102
CAS No.: 21041-10-1
Synonyms: Lycoraminone
Dihydronarwedine (Lycoraminone) is the alkaloid. Dihydronarwedine inhibits 39% activity of glycogen synthase kinase-3β (GSK-3β) at a concentration of 10 μM .
loading...
    loading...
Cat. No.: HY-114270
CAS No.: 1408054-46-5
Target:  

GSK-3

Research Areas:  

Neurological Disease

JGK-263 is an orally active Glycogen synthase kinase-3β (GSK-3β) inhibitor. JGK-263 exhibits neuroprotective effect and can improve motor function. JGK-263 can be used for the research of neurological disease, such as amyotrophic lateral sclerosis (ALS) .
loading...
    loading...
Cat. No.: HY-107529
CAS No.: 1257256-44-2
Target:  

GSK-3

TC-G 24 (Compound 24) is a potent, selective glycogen synthase kinase-3β (GSK-3β) inhibitor with an IC50 of 17.1 nM. TC-G 24 can cross the BBB and can be used for studying many diseases such as type 2 diabetes mellitus, stroke, Alzheimer, and other related diseases .
loading...
    loading...
Cat. No.: HY-136679
CAS No.: 436866-52-3
Target:  

GSK-3

TD114-2 (cmpound 29) is a potent and highly selective inhibitor of glycogen synthase kinase-3β (GSK-3β) (IC50=48 nM). TD114-2 is associated with the hydrogen bond formation of arginine 141 (ARG141) specific to GSK-3β, an amino acid that is often a negatively charged residue in other kinases, which determines the high selectivity of GSK-3β. TD114-2 can be used in the study of diabetes, neurodegenerative diseases and other diseases associated with GSK-3β .
loading...
    loading...
Cat. No.: HY-P3713
CAS No.: 956004-39-0
Target:  

GSK-3

Research Areas:  

Cancer

Presenilin 1 (349-361) is an active petide, and synthetic peptides representing amino acids 349–361 can be phosphorylated by glycogen synthase kinase-3β(GSK3β) in vitro. Presenilin 1 (349-361) can be used for the research of various diseases .
loading...
    loading...
Cat. No.: HY-187680
Target:  

GSK-3

Research Areas:  

Neurological Disease

GSK-3β-IN-30 is a glycogen synthase kinase-3β (GSK-3β) inhibitor. GSK-3β-IN-30 stabilizes its conformation in the binding pocket by occupying the ATP-binding cleft of GSK-3β, forming hydrogen bonds with Lys183 and Ser203, and establishing π-anion interactions with Asp181 and Asp200. GSK-3β-IN-30 can be used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-187681
CAS No.: 889768-87-0
Target:  

GSK-3

Research Areas:  

Neurological Disease

GSK-3β-IN-31 is a glycogen synthase kinase-3β (GSK-3β) inhibitor. GSK-3β-IN-31 binds to the ATP-binding pocket of GSK-3β, forms hydrogen bonds with Lys183 and Ser203, and also engages in π-anion interactions with Asp181 and Asp200 to stabilize the binding conformation. GSK-3β-IN-31 can be used for the research of Alzheimer's disease .
loading...
    loading...
Cat. No.: HY-P705843
Purity:  ≥ 90%, as determined by reducing SDS-PAGE.
Synonyms: GSK3B; Serine/Threonine-Protein kinase GSK3B; glycogen synthase kinase 3 Beta; GSK-3 Beta; glycogen synthase kinase-3 Beta
Species:  
Human
Source:  
sf9 insect cells
loading...
    loading...